1. "Hematologic Malignancies Research"
Formats
  1. Journal Article (1521)
  2. Meeting Abstract (1232)
  3. Review (76)
  4. Editorial (34)
  5. Book Section (32)
  6. Research Letter (25)
  7. Conference Paper (15)
  8. Correspondence (7)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (2950)
  2. Hematologic Malignancies Research (2950)
  3. GSK Faculty (2412)
  4. Department of Medicine (2277)
  5. Hematologic Malignancies, Division of (2078)
  6. Sloan Kettering Institute Faculty (2026)

More Groups

People
  1. Michel Sadelain (582)
  2. David Scheinberg (499)
  3. Alexander Lesokhin (363)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (279)

More People

Years
  1. 2025 (32)
  2. 2024 (108)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (636)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (108)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (674)
  2. Nature Publishing Group (367)
  3. Elsevier Inc. (290)
  4. American Association for Cancer Research (245)
  5. Cell Press (116)
  6. American Society of Clinical Oncology (112)

More Publishers

Results (2950)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer
    Journal Article

    Tello-Lafoz, M.; Srpan, K.; Sanchez, E. E.; Hu, J.; Remsik, J.; Romin, Y.; Calò€, A.; Hoen, D.; Bhanot, U.; Morris, L.; more...
    Immunity (2021)

    Fulltext@MSK | Save
  • Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Research Letter

    Korde, N.; Mastey, D.; Tavitian, E.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Shah, U.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Integrative analysis reveals unique structural and functional features of the Smc5/6 complex
    Journal Article

    Yu, Y.; Li, S.; Ser, Z.; Sanyal, T.; Choi, K.; Wan, B.; Kuang, H.; Sali, A.; Kentsis, A.; Patel, D. J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2021)

    Fulltext@MSK | Save
  • Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy
    Journal Article

    Charles, A.; Bourne, C. M.; Korontsvit, T.; Aretz, Z. E. H.; Mun, S. S.; Dao, T.; Klatt, M. G.; Scheinberg, D. A.
    OncoImmunology (2021)

    Fulltext@MSK | Save
  • Deconvoluting global cytokine signaling networks in natural killer cells
    Journal Article

    Wiedemann, G. M.; Santosa, E. K.; Grassmann, S.; Sheppard, S.; Le Luduec, J. B.; Adams, N. M.; Dang, C.; Hsu, K. C.; Sun, J. C.; Lau, C. M.
    Nature Immunology (2021)

    Fulltext@MSK | Save
  • In vivo library screening identifies the metabolic enzyme aldolase A as a promoter of metastatic lung colonization
    Journal Article

    Tu, Z.; Hou, S.; Zheng, Y.; Abuduli, M.; Onder, T.; Intlekofer, A. M.; Karnoub, A. E.
    iScience (2021)

    Fulltext@MSK | Save
  • Bispecific T-cell engaging antibodies against MUC16 demonstrate efficacy against ovarian cancer in monotherapy and in combination with PD-1 and VEGF inhibition
    Journal Article

    Yeku, O. O.; Rao, T. D.; Laster, I.; Kononenko, A.; Purdon, T. J.; Wang, P.; Cui, Z.; Liu, H.; Brentjens, R. J.; Spriggs, D.
    Frontiers in Immunology (2021)

    Fulltext@MSK | Save
  • Initial whole-genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
    Journal Article

    Maura, F.; Diamond, B.; Maclachlan, K. H.; Derkach, A.; Yellapantula, V. D.; Rustad, E. H.; Hultcrantz, M.; Shah, U. A.; Hong, J.; Landau, H. J.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML
    Journal Article

    Shaffer, B. C.; Le Luduec, J. B.; Park, S.; Devlin, S.; Archer, A.; Davis, E.; Cooper, C.; Nhaissi, M.; Suri, B.; Wells, D.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Natural killer cells: From innate to adaptive features
    Review

    Mujal, A. M.; Delconte, R. B.; Sun, J. C.
    Annual Review of Immunology (2021)

    Fulltext@MSK | Save